Elevian Company
Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent many age-related diseases.
Investors
Founded Date:
2017
Last Funding Type:
Seed
Headquarters:
Allston, Massachusetts, United States
Investors Number:
9
Technology:
Regenerative Medicine
Employee Number:
1-10
Industry:
Biopharma, Biotechnology
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020
Number Of Exists:
Seed
Funding Status:
Seed
Investor Type:
Company
Total Funding:
24333889